Wisconsin-based Bedford Paper has responded to an increase in demand for high-quality tissue products by investing in its third PCMC-supplied tissue converting line.
The company said it had to meet its growing production needs following the outbreak of Covid-19.
It added that the pandemic “continues to cause unprecedented demand on Bedford Paper’s capacity”.
The expansion is planned to break ground in the spring of 2021 and will triple the current facility’s size, giving Bedford Paper nearly 350,000 square feet of manufacturing space.
The growth of the company’s facility footprint in northeast Wisconsin means it will become one of the largest independent tissue converters in the Midwest.
Steve Peters, President of Bedford Paper, said: “We’ve relied on PCMC’s technology and support to keep our business moving forward for nearly a decade.
“We value the fact that PCMC’s machines are engineered and built in the United States, which gives us added confidence in the long-term performance of a significant investment like this one.”
